Steatotic liver disease is the most important somatic determinant of quality of life in patients with obesity: A cross-sectional study.
Charlotte Wilhelmina WernbergMads Fallesen KjerLea Ladegaard GrønkjaerBirgitte Gade JacobsenMette Munk Enok LauridsenPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
MASLD severity was the only somatic determinant of QOL in patients with obesity in this cohort, and a large fraction reported debilitating symptoms. Patients and caregivers should consider the limitations this poses when planning interventions.
Keyphrases
- end stage renal disease
- insulin resistance
- metabolic syndrome
- weight loss
- type diabetes
- newly diagnosed
- chronic kidney disease
- ejection fraction
- physical activity
- weight gain
- copy number
- palliative care
- peritoneal dialysis
- prognostic factors
- risk factors
- depressive symptoms
- body mass index
- gene expression
- skeletal muscle
- patient reported outcomes
- dna methylation
- patient reported